Neuromodulation for Epilepsy


Learning objectives: 

• Understand the pivotal trials that resulted in approval for VNS, DBS, and RNS. 
• Know when to offer neurostimulation to your patients. 
• Be able to advise your patients on what to expect regarding surgery as well as outcomes for the Neuromodulation device chosen. 

Session date: 
10/15/2026 - 3:45pm to 4:30pm EDT
Location: 
Virtual
United States
See map: Google Maps
Add to calendar: 
  • 0.75 AMA PRA Category 1 Credit™
Please login or register to take this course.
Faculty List: 
Program Director(s)

James Leiphart, MD, PhD

has no relevant financial relationships to disclose at this time.

Amy Safadi, MD

has a financial relationship (Consulting Fee) with TG therapeutics ;.
has a financial relationship (Consulting Fee) with Genentech;.
Speaker(s)

Jessica Falco-Walter, MD

has no relevant financial relationships to disclose at this time.